24 May 2013
Keywords: Biocon, Malaysia, Investment, R&D facility, Biomanufacturing
Article | 28 October 2010
Bangalore, India-based biotech firm Biocon (BSE: 532523) is making a big foray into the Malaysian market, saying it will set up ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 October 2010
© 2013 thepharmaletter.com